<?xml version="1.0" encoding="UTF-8"?>
<p>Camostat mesylate is a TMPRSS2 inhibitor. TMPRSS2 is a cellular protease that, together with ACE2, allows SARS-CoV-2 to enter target cells (
 <xref rid="B13" ref-type="bibr">13</xref>). Camostat mesylate, already approved for some forms of cancer and hepatitis, is being tested in ongoing clinical trial against COVID-19.
</p>
